EXPERIMENTAL THERAPEUTICS TARGETING NONDIFFERENTIATED, BASAL-LIKE, TUMORIGENIC PROSTATE CANCER CELLS

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators